HomeNVCT • NASDAQ
add
Nuvectis Pharma Inc
Previous close
$7.68
Day range
$7.68 - $7.68
Year range
$4.55 - $11.52
Market cap
196.72M USD
Avg Volume
91.32K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.79M | 78.80% |
Net income | -7.46M | -79.68% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 35.44M | 106.43% |
Total assets | 35.59M | 105.62% |
Total liabilities | 11.58M | 83.30% |
Total equity | 24.01M | — |
Shares outstanding | 25.61M | — |
Price to book | 8.17 | — |
Return on assets | -62.26% | — |
Return on capital | -95.32% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -7.46M | -79.68% |
Cash from operations | -4.49M | -86.94% |
Cash from investing | — | — |
Cash from financing | 13.14M | 802.06% |
Net change in cash | 8.65M | 1,013.31% |
Free cash flow | -1.86M | -79.84% |
About
Founded
2020
Headquarters
Website
Employees
13
